Funding Details
- Awarder
- YCombinator
- Date Award
- January 05, 2016
- Vertical
- Healthcare,Drug Discovery and Delivery
- Funding URL
- View Funding Page
- Valuation
-
$0
Company Info
- Founding Year
- 2016
- Company Description
- Perlara 1.0 (Feb 2014 - Feb 2019) launched early R&D joint ventures called PerlQuests with highly motivated rare disease families, companies or impact investors. We screened gene-edited patient avatars for repurposable drugs in order to build a predictive R&D engine called ArkBase. We planned to monetize programs based on ArkBase predictions by selectively spinning out asset-centric clinical development NewCos.
Perlara 1.5 (March 2019 - April 2020) was the transition to a one-person virtual clinical development company and when the epalrestat and aripiprazole repurposing trials were launched at Mayo Clinic for the treatment of PMM2-CDG and NGLY1-CDDG, respectively.
Perlara 2.0 (May 2020 --> The first decentralized and distributed biotech
- Market
- Healthcare
- Location
-
Oakland,
CA,
USA; Remote
- Coinvestors
- YCombinator
Links